(30 Aug 2024, 12:17)

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagnostic and pathological services business of Vimta Labs.

Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs 30 crore during FY 2024 and Rs 7 crore in Q1 FY 2025.

More News

(06-Nov-2024 09:11)
Polycab India emerges lowest bidder for Rs 4099 cr BSNL project
(06-Nov-2024 09:28)
SEAMEC update on deployment of its vessel “SEAMEC PRINCESS"
(06-Nov-2024 09:53)
Espire Hospitality to discuss results
(06-Nov-2024 09:53)
Concord Biotech to conduct board meeting

More Company News View Company Information

Hot Pursuit (24-Oct-2024 11:15)
Thyrocare Tech hits 52 week high as Q2 PAT jumps 31% YoY to Rs 27 cr
Results - Announcements (23-Oct-2024 17:48)
Thyrocare Technologies consolidated net profit rises 31.12% in the September 2024 quarter
Corporate News (17-Oct-2024 13:42)
Thyrocare Technologies schedules board meeting
Corporate News (19-Sep-2024 14:29)
Thyrocare Technologies announces cessation of director
Corporate News (30-Aug-2024 12:17)
Thyrocare to acquire diagnostic and pathological services of Vimta Lab
Hot Pursuit (30-Aug-2024 14:30)
Thyrocare Tech to acquire diagnostic and pathological services of Vimta Lab
Corporate News (06-Aug-2024 17:18)
Thyrocare Technologies AGM scheduled

Corporate News

Thyrocare to acquire diagnostic and pathological services of Vimta Lab